Key Record Dates
ClinicalTrials.gov Identifier: | NCT04504825 |
---|---|
Brief Title: | A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis |
First Submitted : | July 20, 2020 |
First Submitted that Met QC Criteria : | August 5, 2020 |
First Posted : | August 7, 2020 |
Last Update Submitted that Met QC Criteria : | May 22, 2023 |
Last Update Posted : | May 23, 2023 |